Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular - Clinical Science

Deep learning enabled automated quantification of technetium pyrophosphate for cardiac amyloidosis

Robert Miller, Aakash Shanbhag, Anna Michalowska, Paul Kavanagh, Joanna Liang, Valerie Builoff, Nowell Fine, Daniel Berman, Damini Dey and Piotr Slomka
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241605;
Robert Miller
1University of Calgary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aakash Shanbhag
2Cedars Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Michalowska
3Cedars-Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Kavanagh
2Cedars Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Liang
3Cedars-Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Builoff
3Cedars-Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nowell Fine
1University of Calgary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Berman
3Cedars-Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damini Dey
2Cedars Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piotr Slomka
3Cedars-Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

241605

Introduction: Transthyretin cardiac amyloidosis (ATTR-CM) is increasingly recognized as a cause of heart failure in older patients, with 99mtechntium pyrophosphate (PYP) imaging frequently used to establish the diagnosis.Visual interpretation of single photon emission computed tomography (SPECT) images is the gold standard for interpretation but is inherently subjective. Manual quantitation of SPECT myocardial PYP activity is time-consuming and not performed clinically. We evaluated different methods for fully automated volumetric quantitation of PYP utilizing segmentation of co-registered anatomical structures from CT attenuation maps.

Methods: Patients who underwent SPECT/CT PYP imaging for suspected ATTR-CM were included. Diagnosis of ATTR-CM was determined using standard criteria. Cardiac chambers and myocardium were segmented from CT attenuation maps using deep learning, then transferred to registered SPECT images to quantify counts in left atrial blood pool and left ventricular myocardium. We evaluated the diagnostic accuracy of three methods for determining radiotracer activity: target-to-background ratio (TBR), cardiac pyrophosphate activity (CPA) and volume of involvement (VOI). We then evaluated their age-adjusted associations with the composite outcome of cardiovascular death or heart failure hospitalization.

Results: In total, 296 patients were included, mean age 74.0 ± 12.0 years, with ATTR-CM diagnosed in 84 (28.4%) patients. Of the quantification methods, CPAand VOI had higher prediction performance for ATTR-CM (both area under the curve [AUC] 0.974, 95% CI 0.950 – 0.998) compared to TBR (AUC 0.951, 95% CI 0.917 – 0.985, p=0.002). Twenty-three patients ATTR-CM experienced cardiovascular death or heart failure hospitalization. Increasing CPA (hazard ratio [HR] 1.35, p=0.041), VOI (HR 1.34, p=0.046), and TBR (HR 1.58, p=0.039) were associated with an increased risk of events.

Conclusions: Deep learning segmentation of co-registered CT attenuation maps allows automatic quantification of hot-spot SPECT imaging such as PYP. This can be used to accurately identify patients with ATTR-CM and may play a role in risk prediction.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Deep learning enabled automated quantification of technetium pyrophosphate for cardiac amyloidosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Deep learning enabled automated quantification of technetium pyrophosphate for cardiac amyloidosis
Robert Miller, Aakash Shanbhag, Anna Michalowska, Paul Kavanagh, Joanna Liang, Valerie Builoff, Nowell Fine, Daniel Berman, Damini Dey, Piotr Slomka
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241605;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Deep learning enabled automated quantification of technetium pyrophosphate for cardiac amyloidosis
Robert Miller, Aakash Shanbhag, Anna Michalowska, Paul Kavanagh, Joanna Liang, Valerie Builoff, Nowell Fine, Daniel Berman, Damini Dey, Piotr Slomka
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241605;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prognostic value of right ventricular glucose metabolism activity by 18F-FDG PET/CT in patients with ischemic heart failure
  • Comparison of 13N-Ammonia PET Myocardial Perfusion Imaging to Coronary Computed Tomography Angiography (cCTA) and CT Fractional Flow Reserve (CT-FFR) in Patients with Stable Angina
  • Assessment of myocardial injury by SPECT myocardial perfusion imaging in patients with COVID-19 infection in a single center after lifting the restrictions in China
Show more Cardiovascular - Clinical Science

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire